Citius Pharmaceuticals Statistics

Total Valuation

CTXR has a market cap or net worth of $75.83 million. The enterprise value is $52.08 million.

Market Cap	75.83M
Enterprise Value	52.08M

Important Dates

The next estimated earnings date is Friday, December 27, 2024, after market close.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

CTXR has 180.73 million shares outstanding. The number of shares has increased by 9.86% in one year.

Current Share Class	180.73M
Shares Outstanding	180.73M
Shares Change (YoY)	+9.86%
Shares Change (QoQ)	+9.29%
Owned by Insiders (%)	6.82%
Owned by Institutions (%)	11.31%
Float	158.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	7.30
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.81
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.00.

Current Ratio	6.75
Quick Ratio	4.31
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.49% and return on invested capital (ROIC) is -27.68%.

Return on Equity (ROE)	-41.49%
Return on Assets (ROA)	-24.74%
Return on Capital (ROIC)	-27.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.81M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTXR has paid $576,000 in taxes.

Income Tax	576,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.90% in the last 52 weeks. The beta is 1.66, so CTXR's price volatility has been higher than the market average.

Beta (5Y)	1.66
52-Week Price Change	-46.90%
50-Day Moving Average	0.45
200-Day Moving Average	0.66
Relative Strength Index (RSI)	52.56
Average Volume (20 Days)	881,408

Short Selling Information

The latest short interest is 12.42 million, so 6.87% of the outstanding shares have been sold short.

Short Interest	12.42M
Short Previous Month	12.77M
Short % of Shares Out	6.87%
Short % of Float	7.85%
Short Ratio (days to cover)	10.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.07M
Pretax Income	-35.62M
Net Income	-39.77M
EBITDA	-41.07M
EBIT	-41.07M
Earnings Per Share (EPS)	-$0.24

Full Income Statement

Balance Sheet

The company has $17.91 million in cash and $320,011 in debt, giving a net cash position of $17.59 million or $0.10 per share.

Cash & Cash Equivalents	17.91M
Total Debt	320,011
Net Cash	17.59M
Net Cash Per Share	$0.10
Equity (Book Value)	86.28M
Book Value Per Share	0.47
Working Capital	23.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-29.09M
Capital Expenditures	n/a
Free Cash Flow	-29.09M
FCF Per Share	-$0.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTXR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.86%
Shareholder Yield	-9.86%
Earnings Yield	-52.34%
FCF Yield	-38.29%

Analyst Forecast

The average price target for CTXR is $5.00, which is 1,091.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	1,091.61%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 9, 2017. It was a reverse split with a ratio of 0.06667:1.

Last Split Date	Jun 9, 2017
Split Type	Reverse
Split Ratio	0.06667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1